–
Fulcrum Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−81.1
FY22:
−113
FY23:
−111
FY24:
−21.9
FY25:
−84.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
−78.5
FY22:
–
FY23:
−108
FY24:
–
FY25:
−83.4
(positive)
Change from FY21 to FY25
millions USD
FY21:
−80.8
FY22:
–
FY23:
−97.3
FY24:
–
FY25:
−74.9
(positive)
Change from FY21 to FY25
millions USD
FY21:
−80.8
FY22:
−110
FY23:
−97.3
FY24:
−9.73
FY25:
−74.9
All amounts in millions USD